Involvement of adenosine A2 receptors in the changes of tissue factor-dependent coagulant activity induced by

Tohru Watanabe1, Shogo Tokuyama, Masako Yasuda

  • 1Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan.

Insights

Adenosine receptors, specifically the A2 subtype, reduce tissue factor activity and polymorphonuclear leukocyte adhesion to endothelial cells. This suggests a key role for adenosine A2 receptors in regulating these inflammatory and coagulation processes.

Area of Science:

  • Immunology
  • Vascular Biology
  • Pharmacology

Background:

  • Polymorphonuclear leukocytes (PMNs) increase tissue factor (TF) activity in endothelial cells via adhesion.
  • The precise mechanisms regulating PMN-endothelial cell interactions and TF activity are not fully understood.

Purpose of the Study:

  • To investigate the role of adenosine receptors in modulating TF activity and PMN-endothelial cell adhesion.
  • To elucidate the specific adenosine receptor subtypes involved in these processes.

Main Methods:

  • Experiments involved pretreating endothelial cells with adenosine and its receptor agonists/antagonists.
  • Assays measured TF activity and the degree of PMN adhesion to endothelial cells.
  • Specific adenosine receptor agonists (CGS-21680, CPCA) and antagonists (DMPX, CPDMX) were utilized.

Main Results:

  • Adenosine, CGS-21680 (A1/A2 agonist), and CPCA (A2 agonist) significantly reduced TF activity and PMN adhesion in a dose-dependent manner.
  • The adenosine A2-receptor antagonist DMPX reversed the inhibitory effects of adenosine on TF activity and adhesion.
  • The adenosine A1-receptor antagonist CPDMX and A1 agonists (CHA, CCPA) did not affect TF activity or adhesion.

Conclusions:

  • Adenosine A2 receptors play a critical role in inhibiting PMN adhesion to endothelial cells.
  • Inhibition of PMN adhesion via adenosine A2 receptors leads to a reduction in TF activity.
  • Adenosine A2-receptor-mediated pathways represent a potential therapeutic target for modulating inflammation and coagulation.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...